Merck KGaA Finds The Right Home For Disease-Modifying OA Agent In Novartis

Licenses Nanobody M6495 To Swiss Firm

 
• By John Davis
Osteoarthritis
Reversing Osteoarthritis Changes Has Proven Difficult • Source: Shutterstock

More from Deals

More from Business